サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1166087

脳室ドレナージの世界市場：現状分析と予測（2022年～2028年）

External Ventricular Drain Market: Current Analysis and Forecast (2022-2028)
出版日: | 発行: UnivDatos Market Insights Pvt Ltd | ページ情報: 英文 154 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
脳室ドレナージの世界市場：現状分析と予測（2022年～2028年）
出版日: 2022年11月01日
発行: UnivDatos Market Insights Pvt Ltd
ページ情報: 英文 154 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 目次
概要

世界の脳室ドレナージの市場規模は、予測期間中に約7％のCAGRで成長すると予測されています。さまざまな神経疾患の有病率の増加、世界の交通事故件数の増加による外傷性脳損傷の増加、急速な技術進歩、研究開発活動の高まりは、市場の成長を促進しています。

当レポートでは、世界の脳室ドレナージ市場について調査しており、市場の洞察、市場動向、競合シナリオ、企業概要など、包括的な情報を提供しています。

目次

第1章 市場イントロダクション

  • 市場の定義
  • 主な目的
  • ステークホルダー
  • 制限

第2章 調査方法または仮定

  • 脳室ドレナージ市場の調査プロセス
  • 脳室ドレナージ市場の調査手法
  • 回答者プロファイル

第3章 市場要約

第4章 エグゼクティブサマリー

第5章 COVID-19が脳室ドレナージ市場に与える影響

第6章 脳室ドレナージ市場の収益（2022年～2028年）

第7章 市場の洞察：用途別

  • 外傷性脳損傷
  • 頭蓋内出血
  • 水頭症
  • その他

第8章 市場の洞察：エンドユーザー別

  • 病院
  • 外来手術センター
  • その他

第9章 市場の洞察：地域別

  • 北米
    • 米国
    • カナダ
    • その他北米
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • その他アジア太平洋
  • 世界のその他の地域

第10章 脳室ドレナージ市場力学

  • 市場促進要因
  • 市場の課題
  • 影響分析

第11章 脳室ドレナージの市場機会

第12章 脳室ドレナージの市場動向

第13章 需要側と供給側の分析

  • 需要側分析
  • 供給側分析

第14章 バリューチェーン分析

第15章 競合シナリオ

  • 競合情勢
    • ポーターのファイブフォース分析

第16章 企業概要

  • Medtronic Plc
  • Spiegelberg Gmbh & Co. Kg
  • Moller Medical Gmbh
  • Braun Melsungen Ag
  • Integra Life Sciences Corporation
  • Pfizer Inc.
  • Cadila Pharmaceuticals
  • Sophysa
  • Fuji Systems
  • Geistlich Pharma Inc.

第17章 免責事項

目次
Product Code: UMHE211280

Global External Ventricular Drain Market is expected to grow at a significant rate of around 7% during the forecast period. The global external ventricular drain market is anticipated to witness an uptick owing to the growing prevalence of various neurological disorders and the rise in traumatic brain injuries due to an increase in the number of road accidents across the world. For instance, According to the World Health Organization, approximately 1.3 million people die every year as a result of road traffic crashes. Between 20 and 50 million more people suffer non-fatal injuries, with many incurring a disability as a result of their injury. Also, as per the United Nations data, in February 2021, nearly 1 in 6 of the world's population, suffer from neurological disorders, such as Alzheimer's and Parkinson's disease, strokes, etc. Furthermore, rapid technological advancement, rising research and development activities and an increasing need for minimally invasive or non-invasive neurosurgeries to reduce trauma and improve patient outcomes are also some of the factors contributing to the growth of the external ventricular drain market across the globe.

Medtronic Plc, Spiegelberg Gmbh & Co. Kg, Moller Medical Gmbh, Braun Melsungen Ag, Integra Life Sciences Corporation, Pfizer Inc., Cadila Pharmaceuticals, Sophysa, Fuji Systems, Geistlich Pharma Inc are some of the key players in the market. Several M&As along with partnerships have been undertaken by these players to facilitate customers with new and innovative products.

 

Insights Presented in the Report

"Amongst application, traumatic brain injury category to witness higher CAGR during the forecast period"

Based on the application, the external ventricular drain market is segmented into traumatic brain injury, intracranial haemorrhage, hydrocephalus, and others. The traumatic brain injury segment accounted for a significant market share in 2020 and it is estimated that it will grow rapidly during the projected timeframe owing to an increase in the number of road accidents leading to rise in the prevalence of traumatic brain injuries. However, the hydrocephalus segment is also expected to grow considerably during the forecast period as it affects a large number of people globally.

"Amongst end-user, the hospitals segment to hold a significant share in the market in 2020"

Based on end-user, the market is fragmented into hospitals, ambulatory surgical centers and others. The hospitals segment is expected to grab a considerable market share in 2020 and is expected to grow with a lucrative CAGR during the forecast period. This can be due to an increased preference for patients to get treatment in hospitals owing to the presence of skilled healthcare professionals, availability of technologically advanced equipment, and a well-established infrastructure.

"North America to hold a significant share in the market"

North America is anticipated to grow at a substantial CAGR during the forecast period. The major factors such as well-established healthcare infrastructure, high incidences of traumatic brain injuries and a growing prevalence of neurovascular disorders in the region. For instance, as per the CDC, stroke is the fifth leading cause of death and over 140,000 people are killed due to cerebrovascular stroke each year in the U.S. Furthermore, rapid technological advancements and the presence of major medical equipment companies are also contributing towards the growth of the market for the external ventricular drain in the region.

Reasons to buy this report:

The study includes market sizing and forecasting analysis validated by authenticated key industry experts.

The report presents a quick review of overall industry performance at one glance.

The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments.

Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.

The study comprehensively covers the market across different segments.

Deep dive regional level analysis of the industry.

Customization Options:

The global external ventricular drain market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

TABLE OF CONTENTS

1 MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the External Ventricular Drain Market
  • 2.2. Research Methodology of the External Ventricular Drain Market
  • 2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE EXTERNAL VENTRICULAR DRAIN MARKET

6 EXTERNAL VENTRICULAR DRAIN MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY APPLICATION

  • 7.1. Traumatic Brain Injury
  • 7.2. Intracranial Haemorrhage
  • 7.3. Hydrocephalus
  • 7.4. Others

8 MARKET INSIGHTS BY END-USER

  • 8.1. Hospitals
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Others

9 MARKET INSIGHTS BY REGION

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
    • 9.1.3. Rest of North America
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of World

10 EXTERNAL VENTRICULAR DRAIN MARKET DYNAMICS

  • 10.1. Market Drivers
  • 10.2. Market Challenges
  • 10.3. Impact Analysis

11 EXTERNAL VENTRICULAR DRAIN MARKET OPPORTUNITIES

12 EXTERNAL VENTRICULAR DRAIN MARKET TRENDS

13 DEMAND AND SUPPLY-SIDE ANALYSIS

  • 13.1. Demand Side Analysis
  • 13.2. Supply Side Analysis

14 VALUE CHAIN ANALYSIS

15 COMPETITIVE SCENARIO

  • 15.1. Competitive Landscape
    • 15.1.1. Porters Fiver Forces Analysis

16 COMPANY PROFILED

  • 16.1. Medtronic Plc
  • 16.2. Spiegelberg Gmbh & Co. Kg
  • 16.3. Moller Medical Gmbh
  • 16.4. Braun Melsungen Ag
  • 16.5. Integra Life Sciences Corporation
  • 16.6. Pfizer Inc.
  • 16.7. Cadila Pharmaceuticals
  • 16.8. Sophysa
  • 16.9. Fuji Systems
  • 16.10. Geistlich Pharma Inc.

17 DISCLAIMER